70934-0634 Ondansetron

Product NDC:

70934-0634

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 4.0

Unit: mg/1

Packages:

Code: 70934-0634-82

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-634-82)

Effective Date: Aug. 18, 2020

Discontinued: Aug. 31, 2023

Code: 70934-0634-84

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-634-84)

Effective Date: July 13, 2021

Discontinued: Jan. 31, 2025

Code: 70934-0634-95

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-634-95)

Effective Date: Aug. 31, 2020

Discontinued: May 31, 2025

Code: 70934-0634-89

Description: 15 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-634-89)

Effective Date: Feb. 7, 2022

Discontinued: Nov. 30, 2024

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox